Biodefense Market Size, Share, Industry, Forecast and outlook (2023-2030)

The market is expected to grow at a CAGR of 5.7% during the forecast period 2023-2030.

Major players are Achaogen Inc, Altimune Inc, Bavarian Nordic A/S, Cleveland BioLabs Inc, Dynavax Technologies Corporation, Dynport Vaccine Company LLC, Zhengzhou YKinspection Enterprise Co Ltd, Chongqing Xishan Science & Technology Co Ltd, Guangzhou Lety Medical Limited.

The North America region is expected to dominate the global biodefense market due to increased government funding, research and development initiatives, and a strong commitment to biodefense.

The U.S. government has a significant role in biodefense, with increased spending on biodefense programs and the development of global health security strategies. The government is focused on protecting against biological warfare threats, reducing bioterrorism risks, and ensuring the availability of products for diagnosing, treating, and preventing diseases caused by potential bioterrorist agents.